Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance

Diabetic Medicine

Volumn 23, Issue 8, 2006, Pages 907-911

  Corpeleijn, E ^a,d   Van Der Kallen, C J H ^b   Kruijshoop, M ^b   Magagnin, M G P ^a   De Bruin, T W A ^b   Feskens, E J M ^c   Saris, W H M ^a   Blaak, E E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Gender; Gene environment interactions; Glucose tolerance; Lipid metabolism; Obesity

Indexed keywords

CD36 ANTIGEN; CYTOSINE; GLUCOSE; INSULIN; THYMINE;

ADULT; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PROMOTER REGION; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTIGENS, CD36; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; POLYMORPHISM, GENETIC;

EID: 33746510936     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01888.x     Document Type: Article

References (25)

1. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, Langenberg CJ et al. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 2000; 279: E146-154.
2. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 2001; 50: 2548-2554.
3. Nozaki S, Tanaka T, Yamashita S, Sohmiya K, Yoshizumi T, Okamoto F et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999; 192: 129-135.
4. Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 2001; 42: 751-759.
5. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, ChengW, Pearce SF, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274: 19055-19062.
6. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21: 76-83.
7. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, Kazdova L et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001; 27: 156-158.
8. Coort SL, Hasselbaink DM, Koonen DP, Willems J, Coumans WA, Chabowski A et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes 2004; 53: 1655-1663.
9. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000; 12: 583-594.
10. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab 2003; 285: E354-362.
11. Lepretre F, Vasseur F, Vaxillaire M, Scherer PE, Ali S, Linton K et al. A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum Mutat 2004; 24: 104.
12. Lepretre F, Linton KJ, Lacquemant C, Vatin V, Samson C, Dina C et al. Genetic study of the CD36 gene in a French diabetic population. Diabetes Metab 2004; 30: 459-463.
13. van Dam RM, Boer JM, Feskens EJ, Seidell JC. Parental history of diabetes modifies the association between abdominal adiposity and hyperglycemia. Diabetes Care 2001; 24: 1454-1459.
14. Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, de Bruin TW, Blaak EE. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Res Clin Pract 2003; 61: 49-58.
15. Kruijshoop M, Feskens EJ, Blaak EE, de Bruin TW. Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clin Chim Acta 2004; 341: 33-40.
16. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation part 1: Diagnosis and Classification of Diabetes Mellitus. WHO technical report Series. Geneva: WHO 1999: 1-59.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Kashiwagi H, Tomiyama Y, Nozaki S, Kiyoi T, Tadokoro S, Matsumoto K et al. Analyses of genetic abnormalities in type ICD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet 2001; 108: 459-466.
19. Pravenec M, Landa V, Zidek V, Musilova A, Kazdova L, Qi N et al. Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 2003; 52: 681-688.
20. Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004; 13: 2197-2205.
21. Furuhashi M, Ura N, Nakata T, Shimamoto K. Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care 2003; 26: 471-474.
22. Stannard SR, Johnson NA. Insulin resistance and elevated triglyceride in muscle: more important for survival than 'thrifty' genes? J Physiol 2004; 554: 595-607.
23. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 2002; 18: S5-9.
24. Gale EA, Gillespie KM. Diabetes and gender. Diabetologia 2001; 44: 3-15.
25. Blaak EE. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.